Zurueck zur Suche

Reporte zur Charge NZ7GR

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

32Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
VA 4 MA 3 NJ 2 NY 2 PA 2 MI 2 ME 2 TN 2 IN 2 NH 1 WI 1 AZ 1

VAERS 2545884

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

schwer
Staat
ME
Alter
44,0
Geschlecht
M
Eingang
29.12.2022
Impfdatum
28.12.2022
Beginn
28.12.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Immediate post-injection reaction Loss of consciousness

Symptomtext

Patient felt lightheaded immediately after receiving Japanese Encephalitis vaccine. This vaccine was the fifth and last vaccine given on 12/28/2022. Patient received vaccine at 4:07 PM and immediately felt lightheaded. Patient was seated on exam table and began to pitch his body forward. Patient was able to lay back on exam table with his feet up. Patient did not lose consciousness and continued to speak with this RN. Patient was provided with a cool compress for his forehead. Patient remained supine for 10 minutes and then patient reported he felt better and was able to sit up and walk without experiencing any dizziness.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
None needed.
Aktuelle Erkrankungen
N/A
Vorgeschichte
Mixed hyperlipidemia, Hematochezia, Constipation, Microhematuria, Renal cyst, Urinary frequency, Insomnia, Acne
Andere Medikamente
Received Hepatitis A, Typhoid, MMR, and COVID-19 booster on 12/28/2022 as well. No medications, supplements, herbal remedies taken at the time of vaccination.
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2520076

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

moderat
Staat
MI
Alter
20,0
Geschlecht
F
Eingang
30.11.2022
Impfdatum
30.11.2022
Beginn
30.11.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Abdominal pain upper Chest discomfort Dizziness Headache Hot flush Hypoaesthesia Limb discomfort Nausea Paraesthesia

Symptomtext

After administering Tdap and Hep A, patient complained of headache, hot flashes, dizziness, nausea. Shortly after she complained of her chest feeling weird, numbness in hands. Patient later stated her feet were tingling and legs were heavy. Patient did say her stomach hurt. Patient was given crackers and juice. Checked vitals, called EMS.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
Provider gave Epinephrine 0.3 mg.
Aktuelle Erkrankungen
Abdominal mass, unspecified abdominal location Acute pharyngitis, Virial URI with cough, Pansinusitis
Vorgeschichte
Asthma
Andere Medikamente
-
Allergien
Ventolin, Adhesive, Baclofen
Vorherige Impfungen
-

VAERS 2233819

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

moderat
Staat
CO
Alter
76,0
Geschlecht
F
Eingang
14.04.2022
Impfdatum
11.04.2022
Beginn
11.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Hypoaesthesia Immediate post-injection reaction Injected limb mobility decreased Joint range of motion decreased Pain in extremity Sensory disturbance

Symptomtext

Immediately following vaccination with Hep A #1 on 04/11/2022, pt reported that her left arm became "numb" and stated that she was unable to move this extremity. Pt asked husband to massage arm while RN obtained an ice pack from vaccine room. Upon coming back to room, pt able to move L arm in a circle. Pt reported that pain began resolving with movement and application of ice. Pt declined opportunity to speak with RN's supervisor. Pt stated that shoulder joint hurt, reporting it "felt like my arm fell out of my socket" while arm was dangling for vaccine administration. RN instructed pt to follow up with provider or urgent care if pain worsens or does not resolve; pt verbalized understanding. RN contacted pt on 04/12/2022 at 11:15 to follow up on pt's report of arm numbness and decreased ROM following vaccination on 4/11/22. During phone call, pt reported that she had improved ROM and less pain in L arm on 04/12/2022. Pt stated that she has bad joints, which she believes caused pain after vaccination after arm was hanging at her side for vaccination. Pt reported that she does not believe the vaccine administration itself caused pain. RN counseled pt to follow up with PCP or urgent care if pain does not resolve and/or if ROM affected; pt verbalized understanding, denied questions or concerns at that time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
During screening, pt reported developing a fever ("about 101.9 degrees") and fatigue on 04/06/2022. Pt stated fever resolved "a couple days ago." Pt reported that s/sx resolved and denied feeling ill on date of vaccination. Per nurse supervisor, okay to vaccinate this pt for Hep A despite pt having sx last week, as sx onset not within incubation period for Hep A. Per supervisor, this guidance came from CDC and agency's medical directior on 04/08/2022 to vaccinate for Hep A as long as pt does not present with severe sx.
Vorgeschichte
Pt reports hx of T2 DM and COPD.
Andere Medikamente
Pt reports taking the following medications regularly: gabapentin 500 mg BID, levothyroxine once daily (dosage unknown), BP medication "325/25" once daily (medication name unknown), allopurinol 300 mg once daily, and metformin 500 mg BID.
Allergien
Pt reports allergy to PCNS, states sx of rxn include pruritis.
Vorherige Impfungen
-

VAERS 2719845

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

mild
Staat
AZ
Alter
79,0
Geschlecht
M
Eingang
30.11.2023
Impfdatum
14.06.2022
Beginn
14.06.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Arthralgia Pain in extremity Sleep disorder

Symptomtext

Reported Symptoms: 10003239:ARTHRALGIA; Narrative: Other Relevant HX: 8/14/23 PACT CPP: "Patient reports since last COVID booster has had chronic arm pain and cannot sleep on the side - has not tried anything for the pain" No other documentation of arm pain from vaccines in 6/2022 in system. Patient did receive two vaccines in same arm according to documentation on that day (COVID booster and Hep A). Other:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2670186

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

mild
Staat
IN
Alter
28,0
Geschlecht
F
Eingang
11.08.2023
Impfdatum
06.07.2023
Beginn
06.07.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered Pain in extremity Wrong product administered

Symptomtext

1) Patient received an expired Hep A vaccine. Expired 6/17/23. Hep A was administered 7/6/23. 2) RN intended to administer Hepatitis B shot. Patient received wrong medication. She received the Meningitis B shot. Patient c/o sore arm. Patient came back to the public health clinic 7/18/23 and received an up to date Hep A and Hep B vaccine at no charge.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2578819

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

mild
Staat
TN
Alter
1,6
Geschlecht
M
Eingang
09.02.2023
Impfdatum
08.02.2023
Beginn
08.02.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Abnormal behaviour Decreased interest Incorrect dose administered Lethargy Product administered to patient of inappropriate age Pyrexia

Symptomtext

Pt given adult dose of vaccine versus peds dosing. No issues with 15 minutes of vaccine. Per Father patient did have fever at home, was whiney and did more hand holding than normal, was "unlike himself". Per Mother patient was feverish and lethargic, disinterested in stuff similar to past vaccinations, no reaction at injection site. Per Father and Mother fever controlled with Tylenol.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
PFO (patent foramen ovale)
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2400282

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

mild
Staat
NH
Alter
1,3
Geschlecht
M
Eingang
03.08.2022
Impfdatum
26.07.2022
Beginn
26.07.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Diarrhoea Incorrect dose administered Irritability Product administered to patient of inappropriate age

Symptomtext

Pediatric patient was inadvertently given adult dose of Hep A. Error was noticed right away, mom was notified and site was consulted as well as the nurse on duty. The website advised to monitor the child, the dose given counts as dose #1 and does not affect the timing on dose #2. Mom called 2 days later (7/28/22) and reported diarrhea and some crankiness. Nurse advised BRAT diet for diarrhea, and continue monitoring.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Diarrhoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2711641

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
MA
Alter
29,0
Geschlecht
M
Eingang
08.11.2023
Impfdatum
21.06.2023
Beginn
21.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

inadvertently administered an expired Havrix; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 29-year-old male patient who received HAV (Havrix) (batch number NZ7GR, expiry date 17-JUN-2023) for prophylaxis. On 21-JUN-2023, the patient received Havrix. On 21-JUN-2023, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: inadvertently administered an expired Havrix). The outcome of the expired vaccine used was unknown. Additional Information: GSK receipt date: 30-Oct-2023 The registered nurse called to inquired that it was still good or they should revaccinate. The reporter did not consent to follow-up. The patient received an expired dose of Havrix, which led to expired vaccine used.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2676279

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
WI
Alter
19,0
Geschlecht
F
Eingang
24.08.2023
Impfdatum
23.06.2023
Beginn
23.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

a patient was administered a dose of Havrix that was expired; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 19-year-old female patient who received HAV (Havrix) (batch number NZ7GR, expiry date 17-JUN-2023) for prophylaxis. On 23-JUN-2023, the patient received Havrix. On 23-JUN-2023, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: a patient was administered a dose of Havrix that was expired). The outcome of the expired vaccine used was unknown. Additional Information: GSK Receipt Date: 21-AUG-2023 The reporter was a Medical Assistant. The reporter consented to follow up. The Vaccine Administration Facility was the same as Primary Reporter. The reporter reported that a patient was administered a dose of Havrix that was expired, which led to expired vaccine used.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2670998

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
VA
Alter
25,0
Geschlecht
F
Eingang
14.08.2023
Impfdatum
10.08.2023
Beginn
10.08.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

patient received Havrix on 10AUG2023 that expired on 17JUN2023; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 25-year-old female patient who received HAV (Havrix 1440 adult) (batch number NZ7GR, expiry date 17-JUN-2023) for prophylaxis. On 10-AUG-2023, the patient received Havrix 1440 adult. On 10-AUG-2023, an unknown time after receiving Havrix 1440 adult, the patient experienced expired vaccine used (Verbatim: patient received Havrix on 10AUG2023 that expired on 17JUN2023). The outcome of the expired vaccine used was unknown. Additional Information: Receipt Date: 10-AUG-2023 The health care professional (HCP) reported that the patient received a dose of Havrix on 10th August 2023 which was expired on 17th June 2023, which led to expired vaccine used. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2666384

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
MA
Alter
47,0
Geschlecht
M
Eingang
04.08.2023
Impfdatum
30.07.2023
Beginn
30.07.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Expired Product Use; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 47-year-old male patient who received HAV (Havrix) (batch number NZ7GR, expiry date 17-JUN-2023) for prophylaxis. On 30-JUL-2023, the patient received Havrix. On 30-JUL-2023, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: Expired Product Use). The outcome of the expired vaccine used was unknown. Additional Information: GSK Receipt Date: 31-JUL-2023 The pharmacist reported the patient was administered a dose of Havrix, which had an expiration date of 17 June 2023, which led to expired vaccine used. The pharmacist was unsure which dose number this was in the series. At the time of reporting, the dose was not repeated. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2664328

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
PA
Alter
54,0
Geschlecht
F
Eingang
01.08.2023
Impfdatum
28.07.2023
Beginn
28.07.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

expired drug used; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 54-year-old female patient who received HAV (Havrix) (batch number NZ7GR, expiry date 17-JUN-2023) for prophylaxis. On 28-JUL-2023, the patient received Havrix. On 28-JUL-2023, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: expired drug used). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 28-JUL-2023 The reporter was a medical assistant. The reporter did not consent to follow-up. The Vaccine Administration Facility was the same as Primary Reporter. The reporter stated that a patient inadvertently received an expired dose of Havrix, which led to expired vaccine used.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2657765

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
NY
Alter
38,0
Geschlecht
M
Eingang
18.07.2023
Impfdatum
22.06.2023
Beginn
22.06.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Pt was administered expired vaccine-reported to GSK.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Descovy, Vitamin D3
Allergien
none
Vorherige Impfungen
-

VAERS 2652857

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
IL
Alter
44,0
Geschlecht
M
Eingang
05.07.2023
Impfdatum
26.06.2023
Beginn
26.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

expired dose administered; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 44-year-old male patient who received HAV (Havrix) (batch number NZ7GR, expiry date 17-JUN-2023) for prophylaxis. On 26-JUN-2023, the patient received Havrix. On 26-JUN-2023, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: expired dose administered). The outcome of the expired vaccine used was unknown. Additional Information: GSK receipt date: 26-JUN-2023 The reporter consented to follow up via email. The vaccine administration facility was the same as primary reporter. The patient received an expired dose of Havrix, which led to expired vaccine used.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2650052

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
ME
Alter
45,0
Geschlecht
M
Eingang
27.06.2023
Impfdatum
22.06.2023
Beginn
22.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

expired dose administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 45-year-old male patient who received HAV (Havrix) (batch number NZ7GR, expiry date 17-JUN-2023) for prophylaxis. On 22-JUN-2023, the patient received Havrix. On 22-JUN-2023, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: expired dose administered). The outcome of the expired vaccine used was unknown. Additional Information: GSK receipt date: 22-JUN-2023 The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up via email. The patient received an expired dose of Havrix, which led to expired vaccine used.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2650046

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
NY
Alter
38,0
Geschlecht
M
Eingang
27.06.2023
Impfdatum
22.06.2023
Beginn
22.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Havrix was administered today on June 22 2023. Havrix expired on June 17th 2023; This non-serious case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 38-year-old male patient who received HAV (Havrix) (batch number NZ7GR, expiry date 17-JUN-2023) for prophylaxis. On 22-JUN-2023, the patient received Havrix. On 22-JUN-2023, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: Havrix was administered today on June 22 2023. Havrix expired on June 17th 2023). The outcome of the expired vaccine used was unknown. Additional Information: GSK Receipt Date: 22-JUN-2023 The reporter consented to follow up. Preferred follow up via email. On the day of reporting, the patient received an expired dose of Havrix, which led to expired vaccine used.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2650035

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
VA
Alter
61,0
Geschlecht
F
Eingang
27.06.2023
Impfdatum
20.06.2023
Beginn
20.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

inadvertently administered an expired Havrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 61-year-old female patient who received HAV (Havrix adult) (batch number NZ7GR, expiry date 17-JUN-2023) for prophylaxis. On 20-JUN-2023, the patient received Havrix adult. On 20-JUN-2023, an unknown time after receiving Havrix adult, the patient experienced expired vaccine used (Verbatim: inadvertently administered an expired Havrix). The outcome of the expired vaccine used was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK receipt date: 20-JUN-2023 It was reported that a patient was inadvertently administered an expired Havrix which led to expired vaccine used. The reporter enquired that should the patient be revaccinated. The reporter did not consent to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2648803

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
FL
Alter
51,0
Geschlecht
F
Eingang
23.06.2023
Impfdatum
22.06.2023
Beginn
22.06.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

Patient has no none adverse event but was made aware that the Havrix that was given on 06/22/23 had expired on 06/17/2023. Patient expressed no concerns or side effects from vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
-
Vorgeschichte
HIV AIDS vitamin d deficiency anemia seasonal allergic rhinitis hypertension bask spasms diabetes
Andere Medikamente
Biktarvy Cholecalciferol Ferrous Sulfate Fluticasone Hydrochlorothiazide Methocarbamol Pravastatin Metformin Lisinopril Amlodipine
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2648274

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
-
Alter
71,0
Geschlecht
M
Eingang
22.06.2023
Impfdatum
19.06.2023
Beginn
19.06.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

administered an expired dose of Havrix; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 71-year-old male patient who received HAV (Havrix) (batch number NZ7GR, expiry date 17-JUN-2023) for prophylaxis. On 19-JUN-2023, the patient received Havrix. On 19-JUN-2023, an unknown time after receiving Havrix, the patient experienced expired vaccine used (Verbatim: administered an expired dose of Havrix). The outcome of the expired vaccine used was unknown. Additional Information: GSK receipt date: 20-JUN-2023 Follow-up ok, HCP facility address and email are in HCP details. The reporter consented to follow up. The patient received an expired dose of Havrix, which led to expired vaccine used

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2641711

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
CA
Alter
16,0
Geschlecht
F
Eingang
06.06.2023
Impfdatum
05.06.2023
Beginn
05.06.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age

Symptomtext

MA Administered vaccines below from the adult state stock to a 16 year old patient with no insurance. Provider will contact patient. - Hep A Havrix adult, Hep B Heplisav Adult, HPV Gardasil 9, and TDAP Boostrix

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2584713

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
MT
Alter
27,0
Geschlecht
M
Eingang
21.02.2023
Impfdatum
15.02.2023
Beginn
15.02.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration Vaccination error

Symptomtext

Hep A dose #2/2 was given too early. It was due March 1st, 2023 and given 2/15/2023. Pt notified while in clinic of the error and understands he will need to repeat the dose 8/15/2023 or later to be a valid dose. Pt verbalizes understanding.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Unknown
Allergien
None
Vorherige Impfungen
-

VAERS 2573441

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
IN
Alter
37,0
Geschlecht
M
Eingang
01.02.2023
Impfdatum
01.11.2022
Beginn
10.01.2023
Tage bis Beginn
70,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Depression Feeling abnormal

Symptomtext

I started to have really bad depression. After about 2 and a half weeks, I went to see the doctor. She did not provide any treatment. She told me to go to see my PCP I scheduled an appointment with my primary care doctor. I am still feeling low, and nothing makes sense. I am still having the same feelings.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Depression
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
HIV
Andere Medikamente
Vitamin B complex; DOVATO
Allergien
N/A
Vorherige Impfungen
Flu vaccine 09/2022, chills, headache, tired and other mild symptoms, lasted for 3 to 4 days

VAERS 2562298

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
MI
Alter
27,0
Geschlecht
M
Eingang
18.01.2023
Impfdatum
16.01.2023
Beginn
16.01.2023
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Underdose

Symptomtext

A pediatric dose of HepB was accidentally administered to client instead of an adult dose. Client was contacted and informed of the incident. Staff also explained that because it was a pediatric dose, it would be considered invalid and he would need to receive an adult dose of HepB to complete the series. Staff scheduled client an appointment on 1/18/23 and an adult dose of HepB was administered. Second, the HPV9 was pulled from the inventory and it should have been taken from the private vaccine inventory. Due to client's age, he does not qualify for program. This dose will be replaced with private pay and private vaccine loss report will be completed by my supervisor.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Underdose
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None reported.
Vorgeschichte
None reported.
Andere Medikamente
None reported.
Allergien
None reported.
Vorherige Impfungen
-

VAERS 2528565

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
NJ
Alter
60,0
Geschlecht
F
Eingang
12.12.2022
Impfdatum
12.11.2022
Beginn
12.11.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration

Symptomtext

1st dose on 12Oct2022, 2nd on 12Nov2022; This case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a 60-year-old female patient who received HAV (Havrix) (batch number NZ7GR, expiry date 17th June 2023) for prophylaxis. Concomitant products included HEPATITIS A VACCINE (HAVRIX), HEPATITIS B VACCINE (ENGERIX B) and HEPATITIS B VACCINE (ENGERIX B). On 12th November 2022, the patient received the 2nd dose of Havrix. On 12th November 2022, unknown after receiving Havrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown. Additional Information: GSK receipt date: 01-DEC-2022 Reporters comment: The reporter reported that patient received the 1st dose of Havrix and an early 2nd dose of Havrix. The patient also received the 1st and 2nd dose of Engerix on the same dates. The reporter consent to follow up. Additional Supportive information: The patient received 2nd dose of havrix, earlier than the recommended interval, which led to shortening of vaccinations schedule. This case had been linked with US2022180223 same reporter. Note-As per source document Engerix B coded as concomitant vaccine.; Sender's Comments: US-GSK-US2022180223:Same reporter

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2528564

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
NJ
Alter
72,0
Geschlecht
F
Eingang
12.12.2022
Impfdatum
12.11.2022
Beginn
12.11.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration

Symptomtext

F1st dose of Havrix on 12Oct2022 and an early 2nd dose on 12Nov2022.; This case was reported by a other health professional via call center representative and described the occurrence of drug dose administration interval too short in a 72-year-old female patient who received HAV (Havrix) (batch number NZ7GR, expiry date 17th June 2023) for prophylaxis. Concomitant products included HEPATITIS A VACCINE (HAVRIX), HEPATITIS B VACCINE (ENGERIX B) and HEPATITIS B VACCINE (ENGERIX B). On 12th November 2022, the patient received the 2nd dose of Havrix. On 12th November 2022, unknown after receiving Havrix, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown. Additional Information: GSK receipt date: 01-DEC-2022 Reporters comment: The patient also received the 1st and 2nd dose of Engerix on the same dates of Havrix on 12th October 2022 and 12th November 2022. The reporter reported that patient received the 1st dose of Havrix and an early 2nd dose. The reporter consent to follow-up. Additional Supportive information: The patient received the 2nd dose earlier than the recommended interval, which led to shortening of vaccinations schedule. ; Sender's Comments: US-GSK-US2022180225:Same reporter

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
HAVRIX; ENGERIX B; ENGERIX B
Allergien
-
Vorherige Impfungen
-

VAERS 2522982

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
VA
Alter
18,0
Geschlecht
M
Eingang
05.12.2022
Impfdatum
17.10.2022
Beginn
17.10.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect dose administered No adverse event Product administered to patient of inappropriate age

Symptomtext

The client got an adult vaccine and should have been pediatric dose client was notified he was ok with the error. No signs or symptoms were noted by the client.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
unknown
Allergien
none
Vorherige Impfungen
-

VAERS 2512291

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
OR
Alter
26,0
Geschlecht
M
Eingang
18.11.2022
Impfdatum
18.11.2022
Beginn
18.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administration error Wrong product administered

Symptomtext

Patient had requested hepatitis B vaccine and was given hepatitis A vaccine in error. He has been notified.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administration error
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None indicated on screening form
Vorgeschichte
None indicated on screening form
Andere Medikamente
Unknown
Allergien
None indicated on screening form
Vorherige Impfungen
-

VAERS 2497670

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
PA
Alter
13,0
Geschlecht
M
Eingang
03.11.2022
Impfdatum
02.11.2022
Beginn
02.11.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect dose administered Product administered to patient of inappropriate age

Symptomtext

Adolescent received one dose of adult Hepatitis A vaccine. Patient was monitored for 30 minutes under supervision of two nurses with no signs and symptoms after observation. No treatment needed. Patient was released to guardian care.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
None
Vorherige Impfungen
-

VAERS 2431214

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
TN
Alter
29,0
Geschlecht
M
Eingang
07.09.2022
Impfdatum
02.09.2022
Beginn
01.09.2022
Tage bis Beginn
-
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

pt was given an extra dose of Hepatitis A. Did not need the third dose.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
Hepatitis C, Psychosis
Vorgeschichte
Hepatitis C and psychosis
Andere Medikamente
Olanzapine
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2413415

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
MN
Alter
20,0
Geschlecht
F
Eingang
17.08.2022
Impfdatum
15.08.2022
Beginn
15.08.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Wrong product administered

Symptomtext

Hepatitis A vaccine was given instead of intended Hepatitis B vaccine. No adverse reactions reported by patient. This was the first Hep A vaccine patient has received.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2402876

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
VA
Alter
19,0
Geschlecht
M
Eingang
05.08.2022
Impfdatum
05.08.2022
Beginn
05.08.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration

Symptomtext

Client received Hepatitis A vaccine #1 on 7/22/22. Client received dose #2 on 8/5/22. The second dose was administered too early. There was no reaction to the vaccine. Client was informed of the error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
Syphilis +, no symptoms
Vorgeschichte
-
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2364421

GLAXOSMITHKLINE BIOLOGICALS · HEP A (HAVRIX) · Charge NZ7GR

gering
Staat
MA
Alter
15,0
Geschlecht
M
Eingang
11.07.2022
Impfdatum
11.07.2022
Beginn
11.07.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Incorrect dose administered No adverse event

Symptomtext

Adult publicly funded dose (1 mL) administered mistakenly instead of pediatric publicly funded dose (0.5 mL). No adverse reaction observed in clinic or reported by child or parents upon notification via telephone approximately 1 hour later. Parents and child notified. Primary care physician of patient notified.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
NKDA
Vorherige Impfungen
-